Imfinzi (durvalumab) - AstraZeneca
Anyara (naptumomab estafenatox) - NeoTX
Gazyva (obinutuzumab) - Roche, Biogen
http://clinicaltrials.gov/ct2/show/NCT03983954
 
Mar 18, 2025
 
Next